123 related articles for article (PubMed ID: 6031541)
1. Beta-glucuronidase activity in serum, cerebrospinal fluid and urine in normal subjects and in neurological and mental patients.
Plum CM
Enzymol Biol Clin (Basel); 1967; 8(2):97-112. PubMed ID: 6031541
[No Abstract] [Full Text] [Related]
2. [Enzyme activity of the cerebrospinal fluid in pathological processes of the central nervous system].
Gromashevskaia LL; Gebesh VV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1971; 71(7):991-1000. PubMed ID: 4332538
[No Abstract] [Full Text] [Related]
3. Fatty acid changes of cerebrospinal fluid in neurological disorders as an index of changes in the blood-brain barrier.
Pazzagli A; Arnetoli G; Pepeu I; Amaducci LA
Neurology; 1970 Aug; 20(8):783-6. PubMed ID: 5465848
[No Abstract] [Full Text] [Related]
4. Cerebrospinal fluid electrolyte disturbances in neurological disorders: with special reference to inorganic phosphate.
Breyer U; Kanig K
Neurology; 1970 Mar; 20(3):247-53. PubMed ID: 5461053
[No Abstract] [Full Text] [Related]
5. [Contribution to the study of mucoproteinuria with the Donaggio test in neuropsychiatric diseases].
Becuş T; Feszt T
Neurol Psihiatr Neurochir; 1968; 13(1):31-8. PubMed ID: 5668485
[No Abstract] [Full Text] [Related]
6. SERUM BETA-GLUCURONIDASE DETERMINATION IN NORMAL SUBJECTS AND IN NEUROLOGICAL AND MENTAL PATIENTS; A PROVISIONAL REPORT.
PLUM CM
Acta Med Okayama (1952); 1963 Aug; 17():175-81. PubMed ID: 14123338
[No Abstract] [Full Text] [Related]
7. [Studies on the activity of leucine and glycine aminopeptidases and beta-glucuronidase in the cerebrospinal fluid and serum in nervous system diseases].
Bieniowa A; Drozdz H
Neurol Neurochir Pol; 1972; 6(2):211-7. PubMed ID: 5030048
[No Abstract] [Full Text] [Related]
8. Measurement of prostaglandin F2alpha levels in human cerebrospinal fluid in normal and pathological conditions.
Wolfe LS; Mamer OA
Prostaglandins; 1975 Feb; 9(2):183-92. PubMed ID: 1135435
[TBL] [Abstract][Full Text] [Related]
9. Citrate and alpha-ketoglutarate in cerebrospinal fluid and blood.
Haerer AF
Neurology; 1971 Oct; 21(10):1059-65. PubMed ID: 5165306
[No Abstract] [Full Text] [Related]
10. Comparison of concentration of orosomucoid in serum and cerebrospinal fluid in different neurological diseases.
Vrethem M; Ohman S; von Schenck H; Forsberg P; Olsson JE
Acta Neurol Scand; 1987 May; 75(5):328-31. PubMed ID: 3618110
[TBL] [Abstract][Full Text] [Related]
11. [Changes in the cerebrospinal fluid pH in nervous system diseases].
Zhang CG
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Sep; 15(3):167-9. PubMed ID: 7151578
[No Abstract] [Full Text] [Related]
12. [Cerebrospinal fluid proteins in multiple sclerosis].
Dupelj M; Hamel-Puskarić N; Arko K
Neuropsihijatrija; 1966; 14(1):51-7. PubMed ID: 5191198
[No Abstract] [Full Text] [Related]
13. Cerebrospinal fluid proteins and serum immunoglobulins. Occurrence in multiple sclerosis and other neurological diseases: comparative measurement of gamma-globulin and the IgG class.
Fischer-Williams M; Roberts RC
Arch Neurol; 1971 Dec; 25(6):526-34. PubMed ID: 4107216
[No Abstract] [Full Text] [Related]
14. Guanosine 3'-5'-monophosphate in the CSF of neurological patients.
Trabucchi M; Cerri C; Spano PF; Kumakura K
Arch Neurol; 1977 Jan; 34(1):12-3. PubMed ID: 188401
[TBL] [Abstract][Full Text] [Related]
15. Relationship between serum and cerebrospinal fluid folate.
Reynolds EH; Gallagher BB; Mattson RH; Bowers M; Johnson AL
Nature; 1972 Nov; 240(5377):155-7. PubMed ID: 4564990
[No Abstract] [Full Text] [Related]
16. [The relationship between the cerebrospinal fluid complement and the blood complement titer in various mental disorders].
Krasil'nikova MN
Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(4):599-603. PubMed ID: 5687875
[No Abstract] [Full Text] [Related]
17. [IgM immunoglobulin in cerebrospinal fluid in cases of multiple sclerosis (preliminary report)].
Wajgt A
Neurol Neurochir Pol; 1975; 9(3):327-9. PubMed ID: 1153062
[TBL] [Abstract][Full Text] [Related]
18. [Electrophoretic composition of cerebrospinal fluid proteins in selected chronic diseases of the central nervous system in children].
Kaciński M; Adamczyk A; Wyszkowski J; Sokołowski A
Pediatr Pol; 1981; 56(11-12):1291-6. PubMed ID: 7339555
[No Abstract] [Full Text] [Related]
19. [Cerebrospinal fluid electrophoresis: a method of identification of oligoclonal bands. Comparison with the quantitative values of cerebrospinal fluid IgG and with the Link-Tibbling index].
Carrieri P; Pisani G
Acta Neurol Quad (Napoli); 1979; 39():110-5. PubMed ID: 555226
[No Abstract] [Full Text] [Related]
20. [Determination of guanidinoacetic acid concentration in serum and cerebrospinal fluid].
Szilágyi KA
Acta Physiol Acad Sci Hung; 1970; 38(4):405-10. PubMed ID: 5521451
[No Abstract] [Full Text] [Related]
[Next] [New Search]
